Oregon Public Employees Retirement Fund’s Protagonist Therapeutics PTGX Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio PTGX Stock Details PTGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68M	Buy	13,694 +238	+2%	+$24.9K	0.02%	654
2026 Q1	$1.42M	Buy	13,456 +63	+0.5%	+$5.58K	0.02%	671
2025 Q4	$1.17M	Buy	13,393 +193	+1%	+$15.8K	0.01%	761
2025 Q3	$877K	Sell	13,200 -1,000	-7%	-$56.8K	0.01%	916
2025 Q2	$785K	Buy	14,200 +500	+4%	+$24K	0.01%	905
2025 Q1	$663K	Sell	13,700 -300	-2%	-$12.6K	0.01%	990
2024 Q4	$540K	Buy	14,000 +100	+0.7%	+$4.36K	0.01%	1118
2024 Q3	$626K	Buy	+13,900	New	+$562K	0.01%	1056

Other funds holding PTGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Oregon Public Employees Retirement Fund's PTGX Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Protagonist Therapeutics (PTGX) stake by 1.8% in Q2 2026, buying an estimated $24.9K and bringing the position to 13,694 shares worth $1.68M. The position accounts for 0.02% of the portfolio, ranked #654.

Oregon Public Employees Retirement Fund first reported a position in PTGX in Q3 2024 and has held it in 8 quarters since. 134 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

Oregon Public Employees Retirement Fund held 13,694 shares of Protagonist Therapeutics worth $1.68M as of Q2 2026.
Oregon Public Employees Retirement Fund bought 238 Protagonist Therapeutics shares in Q2 2026, an estimated $24.9K.
Protagonist Therapeutics made up 0.02% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #654 holding.
Oregon Public Employees Retirement Fund first reported a position in Protagonist Therapeutics in Q3 2024 and has held it in 8 quarters since.
134 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.